CORT – corcept therapeutics incorporated (US:NASDAQ)
Stock Stats
News
12/16
08:07 am
cort
Low
Corcept's Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism [Yahoo! Finance]
12/16
08:00 am
cort
Medium
Corcept’s Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism
12/12
04:05 pm
cort
Medium
Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes
12/11
04:19 pm
cort
Medium
Corcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS) [Yahoo! Finance]
12/11
04:05 pm
cort
Low
Corcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)
10/30/2024
04:05 pm
CORT
1.0%
BEAT
7/29/2024
04:05 pm
CORT
3.9%
BEAT
5/1/2024
04:05 pm
CORT
4.9%
BEAT
2/15/2024
04:07 pm
CORT
-9.2%
BEAT
10/31
08:35 am
Reiterates
Buy
Buy
HC Wainwright
High
17.9%
10/18
03:33 pm
Reiterates
Buy
Buy
Sandler O'Neill
Low
-0.3%
10/18
03:33 pm
Reiterates
Buy
Buy
Sandler O'Neill
Low
-0.3%
12/12
04:59 pm
cort
Low
Form 4 CORCEPT THERAPEUTICS For: Dec 10 Filed by: Swisher Daniel N JR
12/10
10:00 am
cort
Low
Form 144 CORCEPT THERAPEUTICS Filed by: Swisher Daniel N JR
12/4
08:03 pm
cort
Medium
Form 4 CORCEPT THERAPEUTICS For: Dec 02 Filed by: Guyer William
12/4
07:52 pm
cort
Medium
Form 4 CORCEPT THERAPEUTICS For: Dec 02 Filed by: Maduck Sean
12/4
07:42 pm
cort
Medium
Form 4 CORCEPT THERAPEUTICS For: Dec 02 Filed by: Robb Gary Charles
Show more
Top News Gainers
8/1 Q2/2019 6/30/2019 EPS 0.250 ZacksConsensus 0.180 ActVsEst 0.070 - Beat 14.1%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
Top News Decliners
3/5 Form 5 CORCEPT THERAPEUTICS For: Dec 31 Filed by: BAKER G LEONARD JR -6.8%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3